US Stock MarketDetailed Quotes

DSGN Design Therapeutics

Watchlist
  • 5.970
  • -0.180-2.93%
Close Nov 27 16:00 ET
338.03MMarket Cap-7023P/E (TTM)

About Design Therapeutics Company

Design Therapeutics, Inc. operates as a biotechnology company that develops therapies for serious degenerative disorders. It is created to design, develop and commercialize a novel class of small molecule therapeutic candidates (GeneTACs) designed to directly address the underlying basis of genetic disease. The company was founded by Pratik Shah and Aseem Z. Ansari on December 18, 2017 and is headquartered in Carlsbad, CA.

Company Profile

SymbolDSGN
Company NameDesign Therapeutics
Listing DateMar 26, 2021
Issue Price20.00
Founded2017
CEODr. Pratik Shah, PhD
MarketNASDAQ
Employees124
Fiscal Year Ends12-31
Address6005 Hidden Valley Road,Suite 110
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92011
Phone1-858-293-4900
Websitehttp://www.designtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pratik Shah, PhD
  • Chairperson of the Board, President, Chief Executive Officer and Principal Financial Officer
  • 6.32M
  • Dr. Jae B. Kim, M.D.
  • Chief Medical Officer
  • --
  • Dr. Sean Jeffries, PhD
  • Chief Operating Officer
  • 1.28M
  • Julie Burgess
  • Chief Accounting Officer
  • --
  • Dr. Stella Xu, PhD
  • Independent Director
  • 94.20K
  • Dr. Heather Berger, PhD
  • Independent Director
  • 94.20K
  • Deepa Prasad
  • Independent Director
  • 94.20K
  • Dr. Arsani William, M.D.
  • Independent Director
  • 104.20K
  • Dr. Simeon J. George, M.B.A.,M.D.
  • Lead Independent Director
  • 95.70K
  • Dr. Rodney W. Lappe, PhD
  • Independent Director
  • 228.56K
  • John P. Schmid
  • Independent Director
  • 106.70K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data